1. Home
  2. KOSS vs IRD Comparison

KOSS vs IRD Comparison

Compare KOSS & IRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOSS
  • IRD
  • Stock Information
  • Founded
  • KOSS 1953
  • IRD 2018
  • Country
  • KOSS United States
  • IRD United States
  • Employees
  • KOSS N/A
  • IRD N/A
  • Industry
  • KOSS Consumer Electronics/Appliances
  • IRD
  • Sector
  • KOSS Consumer Staples
  • IRD
  • Exchange
  • KOSS Nasdaq
  • IRD NYSE
  • Market Cap
  • KOSS 39.9M
  • IRD 38.8M
  • IPO Year
  • KOSS N/A
  • IRD N/A
  • Fundamental
  • Price
  • KOSS $4.56
  • IRD $0.76
  • Analyst Decision
  • KOSS
  • IRD Strong Buy
  • Analyst Count
  • KOSS 0
  • IRD 2
  • Target Price
  • KOSS N/A
  • IRD $7.00
  • AVG Volume (30 Days)
  • KOSS 41.8K
  • IRD 197.5K
  • Earning Date
  • KOSS 05-08-2025
  • IRD 05-15-2025
  • Dividend Yield
  • KOSS N/A
  • IRD N/A
  • EPS Growth
  • KOSS N/A
  • IRD N/A
  • EPS
  • KOSS N/A
  • IRD N/A
  • Revenue
  • KOSS $12,289,961.00
  • IRD $10,992,000.00
  • Revenue This Year
  • KOSS N/A
  • IRD $37.05
  • Revenue Next Year
  • KOSS N/A
  • IRD $67.67
  • P/E Ratio
  • KOSS N/A
  • IRD N/A
  • Revenue Growth
  • KOSS N/A
  • IRD N/A
  • 52 Week Low
  • KOSS $2.30
  • IRD $0.65
  • 52 Week High
  • KOSS $18.73
  • IRD $2.18
  • Technical
  • Relative Strength Index (RSI)
  • KOSS 46.60
  • IRD N/A
  • Support Level
  • KOSS $4.21
  • IRD N/A
  • Resistance Level
  • KOSS $4.69
  • IRD N/A
  • Average True Range (ATR)
  • KOSS 0.34
  • IRD 0.00
  • MACD
  • KOSS 0.05
  • IRD 0.00
  • Stochastic Oscillator
  • KOSS 76.71
  • IRD 0.00

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA), and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

Share on Social Networks: